Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study

Volume: 67, Issue: 4, Pages: 876 - 878
Published: Oct 1, 2017
Abstract
The introduction of direct antiviral drugs (DAAs) has revolutionized the treatment of hepatitis C virus (HCV), with sustained virologic response rates of more than 90% in most patient populations. [1] Pawlotsky J.-M. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology. 2014; 146: 1176-1192 Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar However, it has been suggested that interferon-free HCV...
Paper Details
Title
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Published Date
Oct 1, 2017
Volume
67
Issue
4
Pages
876 - 878
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.